Prasugrel and bivalirudin for primary angioplasty: early results on stent thrombosis and bleeding

Int J Cardiol. 2011 Dec 1;153(2):222-4. doi: 10.1016/j.ijcard.2011.09.059. Epub 2011 Oct 13.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary* / adverse effects
  • Cohort Studies
  • Drug Therapy, Combination
  • Female
  • Hemorrhage / drug therapy*
  • Hemorrhage / epidemiology
  • Hemorrhage / etiology
  • Hirudins / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Peptide Fragments / administration & dosage*
  • Piperazines / administration & dosage*
  • Prasugrel Hydrochloride
  • Recombinant Proteins / administration & dosage
  • Stents* / adverse effects
  • Thiophenes / administration & dosage*
  • Thrombosis / drug therapy*
  • Thrombosis / epidemiology
  • Thrombosis / etiology
  • Time Factors

Substances

  • Hirudins
  • Peptide Fragments
  • Piperazines
  • Recombinant Proteins
  • Thiophenes
  • Prasugrel Hydrochloride
  • bivalirudin